Table 5.

5-HT concentration in MA, MO, both migraine patients (MA+MO) and control subjects regarding different genotypes of 5-HTTLPR, HCRTR1 G1222A, and *G29A.

	Controls	MA	MO	Migraine patients	p (I)	p (II)
5-HTTLPR
SS	0.057 ± 0.053	0.165 ± 0.0351	0.086 ± 0.104	0.111 ± 0.095	0.03671	0.1519
SL	0.092 ± 0.098	0.122 ± 0.095	0.093 ± 0.076	0.106 ± 0.086	0.2049	0.1724
LL	0.106 ± 0.087	0.110 ± 0.104	0.072 ± 0.093	0.084 ± 0.097	0.0716	0.0951
HCRTR1 G1222A
GG	0.101 ± 0.102	0.140 ± 0.0572	0.074 ± 0.078	0.106 ± 0.075	0.03752	0.4233
GA	0.094 ± 0.085	0.130 ± 0.109	0.083 ± 0.094	0.098 ± 0.100	0.1298	0.8161
AA	0.083 ± 0.077	0.093 ± 0.095	0.091 ± 0.075	0.092 ± 0.083	0.8636	0.6301
HCRTR1 *G29A
GG	0.095 ± 0.089	0.137 ± 0.0943,4	0.084 ± 0.089	0.103 ± 0.094	0.00433,4	0.6078
GA	0.083 ± 0.111	0.062 ± 0.066	0.080 ± 0.064	0.070 ± 0.063	0.7965	0.8366

The values in each cell represent: mean ± standard deviation. MA, migraine with aura, MO, migraine without aura. Kruskal-Wallis test (p I) and Mann-Whitney test (p II). Statistical significance at p < 0.05:¹between MA and controls (p I); ²between MA and MO (p I); Statistical significance at p < 0.01: ³between MA and controls, ⁴between MA and MO (p I).